Skip to main content
. 2020 Jan 9;146(3):237–246. doi: 10.1001/jamaoto.2019.4193

Table 3. Generalized Linear Regression Analysis of Overall Costs in the 30-Day Initial Posttreatment Period.

Variable Estimate (95% CI) Mean Incremental Difference (2018 USD), $
Intercept 9.5261 (9.4316 to 9.6206) 15 203
Aged 40-64 y 0.0163 (0.0011 to 0.0314) 247
Goiter 0.0575 (0.0026 to 0.1123) 880
Thyroiditis 0.0939 (0.0357 to 0.1520) 1482
Cancer 0.1196 (0.0648 to 0.1743) 1819
Female sex −0.0998 (−0.1202 to −0.0795) −1518
Comorbidity score
1 0.1680 (0.1314 to 0.2046) 2754
≥2 0.4386 (0.3393 to 0.5379) 8332
Region
North central 0.2204 (0.1953 to 0.2456) 3580
West 0.0670 (0.0401 to 0.0940) 1042
Median income quintile
High 0.1087 (0.0777 to 0.1396) 1713
Very high 0.1351 (0.1061 to 0.1641) 2148
High MSA volume −0.1272 (−0.1514 to −0.1031) −1882
Central neck dissection 0.1102 (0.0883 to 0.1321) 1740
Lateral neck dissection 0.3692 (0.3345 to 0.4038) 6618
RLN injury 0.3494 (0.2739 to 0.4249) 6309
Parathyroid reimplantation 0.1055 (0.0839 to 0.1271) 1674
Magnesium disorder 0.1932 (0.1398 to 0.2466) 3227
Hypocalcemia 0.1420 (0.1216 to 0.1624) 2259

Abbreviations: MSA, metropolitan statistical area; RLN, recurrent laryngeal nerve; USD, US dollars.